Kimvent Q2 Oral Care Kit

Kimvent Q2 Oral Care Kit

Kimvent Q2 Oral Care Kit Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Stop use and ask a doctor if

Swelling, rash, or fever develop.
Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting occurs.

Do not use more than 2 days or administer to children under 3 years of age unless directed by a physician.

Keep out of reach of children under 3 years of age.

Stop use and ask a doctor if

Swelling, rash, or fever develop.
Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting occurs.

Do not use more than 2 days or administer to children under 3 years of age unless directed by a physician.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Aids in the removal of phlegm, mucus, or other secretions in the temporary relief of discomfort due to occasional sore throat and sore mouth.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Sources

Kimvent Q2 Oral Care Kit Manufacturers

Halyard Health

Kimvent Q2 Oral Care Kit | Halyard Health

Topical dosage for adults and children 3 years of age and older is a rinse used no more than 4 times daily. For children under 3 years of age, there is no recommended dosage except under the advice and supervision of a dentist or doctor. Use only under health care practitioners supervision.

No Recall
Kimberly-clark Corporation

Kimvent Q2 Oral Care Kit | Avkare, Inc.

Dosage depends on the severity of the disease and the response of the patient. Patients should be continually monitored for signs that indicate dosage adjustment is necessary, such as remission or exacerbations of the disease and stress (surgery, infection, trauma)(see WARNINGS and PRECAUTIONS, General).
Addison's Disease
In Addison's disease, the combination of fludrocortisone acetate tablets with a glucocorticoid such as hydrocortisone or cortisone provides substitution therapy approximating normal adrenal activity with minimal risks of unwanted effects.
The usual dose is 0.1 mg of fludrocortisone acetate tablets daily, although dosage ranging from 0.1 mg three times a week to 0.2 mg daily has been employed. In the event transient hypertension develops as a consequence of therapy, the dose should be reduced to 0.05 mg daily. Fludrocortisone acetate tablets are preferably administered in conjunction with cortisone (10 mg to 37.5 mg daily in divided doses) or hydrocortisone (10 mg to 30 mg daily in divided doses).
Salt-Losing Adrenogenital Syndrome
The recommended dosage for treating the salt-losing adrenogenital syndrome is 0.1 mg to 0.2 mg of fludrocortisone acetate tablets daily.

No Recall

Login To Your Free Account